TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19747986

Group type: EXPERIMENTAL
Intervention: Induction therapy with PEG interferon alfa-2b 3.0 mcg/kg/wk for 12 weeks followed by PEG interferon alfa-2b 1.5 mcg/kg/wk for 36 weeks and ribavirin 13 +/- 2 mg/kg daily for 48 weeks
Number of subjects: 610

Group type: COMPARATOR
Intervention: Standard of care (SOC) with PEG interferon alfa-2b 1.5 mcg/kg weekly for 48 weeks and ribavirin 13 +/- 2 mg/kg daily for 48 weeks
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: Induction therapy
Number of subjects: 610

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 610

Group type: EXPERIMENTAL
Intervention: Induction therapy in patients weighing more than 85 kg
Number of subjects: 610

Group type: COMPARATOR
Intervention: Standard of care (SOC) in patients weighing more than 85 kg
Number of subjects: 610
Study: 18477077

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided lateral sagittal infraclavicular block
Number of subjects: 80

Group type: COMPARATOR
Intervention: Nerve stimulation-guided lateral sagittal infraclavicular block
Number of subjects: 80
Study: 15950851

Group type: EXPERIMENTAL
Intervention: Droperidol (50 mug) with morphine (1 mg) via PCA
Number of subjects: 179

Group type: COMPARATOR
Intervention: Control (1 mg morphine via PCA)
Number of subjects: 179
Study: 12730085

Group type: EXPERIMENTAL
Intervention: Transdermal 17beta‐estradiol (E2) 50 microg (tE2 group, n=33)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Oral E2 1 mg (oE2 group, n=37)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Oral E2 1 mg combined with gestodene 25 microg (oE2+G group, n=33)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebo (n=49)
Number of subjects: 152
Study: 10493334

Group type: EXPERIMENTAL
Intervention: PNCRM7 vaccine
Number of subjects: 302

Group type: COMPARATOR
Intervention: PNCRM7 vaccine with hepatitis B vaccine
Number of subjects: 302

Group type: COMPARATOR
Intervention: PNCRM7 vaccine with DTaP and HbOC
Number of subjects: 302
Study: 9020807

Group type: EXPERIMENTAL
Intervention: Dichotically presented 100/s click trains amplitude modulated with random sequences of 50 or 100 ms square wave-intervals, alternating sound intensities at 60 dB and 80 dB levels with an IID of 20 dB every 2 s.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monotically or diotically presented stimuli (not specified in detail).
Number of subjects: 0
Study: 1815968

Group type: EXPERIMENTAL
Intervention: Food
Number of subjects: 21

Group type: COMPARATOR
Intervention: Milk
Number of subjects: 21

Group type: COMPARATOR
Intervention: Fasting conditions
Number of subjects: 21
Study: 6125156

Group type: EXPERIMENTAL
Intervention: Triazolam 0.5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Flunitrazepam 2.0 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Triazolam 1.0 mg
Number of subjects: 0
Study: 31270136

Group type: EXPERIMENTAL
Intervention: Automated segmentation method for total kidney volume (TKV) measurement
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Automated segmentation method for total liver volume (TLV) measurement
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Longitudinal analysis of TKV
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Longitudinal analysis of TLV
Number of subjects: 100
Study: 29567358

Group type: EXPERIMENTAL
Intervention: Topical VTP‐38543 (0.05%, 0.15%, and 1.0%) applied twice daily for 28 days
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo (vehicle control)
Number of subjects: 104
Study: 26611780

Group type: EXPERIMENTAL
Intervention: Probiotic group (n = 55) ingested daily 9 log10 colony‐forming units of L. salivarius PS2 from approximately week 30 of pregnancy until delivery
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo group (n = 53) received a placebo
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Probiotic group (n = 55)
Number of subjects: 108
Study: 25202937

Group type: EXPERIMENTAL
Intervention: Segmental epidural steroid injection (80 mg of triamcinolone)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Care as usual (Control group)
Number of subjects: 63
Study: 22227611

Group type: EXPERIMENTAL
Intervention: Told alcohol (0.4 g/kg ethanol)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Told placebo (0.0 g/kg ethanol)
Number of subjects: 96
Study: 19514827

Group type: EXPERIMENTAL
Intervention: Individually tailored exercise intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison health and wellness intervention
Number of subjects: 0
Study: 17959982

Group type: EXPERIMENTAL
Intervention: Gabapentin 600 mg
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study: 15878752

Group type: EXPERIMENTAL
Intervention: GRalpha
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: RANK
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: CTR
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: SID score
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Correlation of marker expression
Number of subjects: 37
Study: 12534378

Group type: EXPERIMENTAL
Intervention: Intravenous ketorolac 30 mg
Number of subjects: 108

Group type: COMPARATOR
Intervention: Rectal diclofenac 50 mg
Number of subjects: 108
Study: 11214945

Group type: EXPERIMENTAL
Intervention: Adrenalin
Number of subjects: 40

Group type: COMPARATOR
Intervention: Terlipressin
Number of subjects: 40
Study: 9120651

Group type: EXPERIMENTAL
Intervention: Resident education (lecture, videotape, individual review)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: Patient education (pamphlets, discussions)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 250
Study: 1574244

Group type: EXPERIMENTAL
Intervention: High-dose etoposide (1,500-2,500 mg/m2)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: High-dose etoposide (2,000 mg/m2 or greater)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: High-dose etoposide (1,500 mg/m2)
Number of subjects: 23
Study: 2864849

Group type: EXPERIMENTAL
Intervention: Esmolol (mean dosage 142 +/- 100 micrograms/kg/min, range 50 to 300 micrograms/kg/min)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Nitroprusside (mean dose 1.6 +/- 1.3 micrograms/kg/min, range 0.5 to 2.75 micrograms/kg/min)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Esmolol
Number of subjects: 12

Group type: COMPARATOR
Intervention: Nitroprusside
Number of subjects: 12
Study: 31356409

Group type: EXPERIMENTAL
Intervention: Home-based computerized cognitive training (CCT) for 8 weeks
Number of subjects: 46

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 46
Study: 29462224

Group type: EXPERIMENTAL
Intervention: Tavaborole 5% topical treatment
Number of subjects: 0
Study: 27108476

Group type: EXPERIMENTAL
Intervention: Immediate non-surgical periodontal therapy
Number of subjects: 475

Group type: COMPARATOR
Intervention: Delayed non-surgical periodontal therapy (Control)
Number of subjects: 475
Study: 24675394

Group type: EXPERIMENTAL
Intervention: Standard AI treatment plus educational materials (EMs)
Number of subjects: 2758

Group type: COMPARATOR
Intervention: Standard AI treatment
Number of subjects: 2758
Study: 22523314

Group type: EXPERIMENTAL
Intervention: Right ventricle-pulmonary artery shunt (RVPAS)
Number of subjects: 549

Group type: COMPARATOR
Intervention: Modified Blalock‐Taussig shunt
Number of subjects: 549
Study: 20508941

Group type: EXPERIMENTAL
Intervention: Exercise training for 6 months
Number of subjects: 21

Group type: COMPARATOR
Intervention: Acute exercise (GXT)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 21
Study: 18456568

Group type: EXPERIMENTAL
Intervention: rifaximin therapy (1200 mg/day for 10 days)
Number of subjects: 113

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: rifaximin therapy (after placebo)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: rifaximin therapy (for patients with negative BTs)
Number of subjects: 113
Study: 16181529

Group type: EXPERIMENTAL
Intervention: CHD Capsules (CHDC)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Isosorbide dinitrate (ID)
Number of subjects: 93

Group type: COMPARATOR
Intervention: Compound Prescription Danshen Droplet Pills (CPDDP)
Number of subjects: 93
Study: 12897564

Group type: EXPERIMENTAL
Intervention: Fiberoptic endoscopic evaluation of swallowing
Number of subjects: 8000000
Study: 10381807

Group type: EXPERIMENTAL
Intervention: Codeine 120 mg with placebo
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Codeine 120 mg with quinidine 100 mg
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 8682138

Group type: EXPERIMENTAL
Intervention: Atenolol 50 mg bd
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: Nifedipine SR 20 mg bd
Number of subjects: 608

Group type: EXPERIMENTAL
Intervention: Combination of atenolol and nifedipine
Number of subjects: 608

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 608
Study: 1986659

Group type: EXPERIMENTAL
Intervention: Oral transmucosal fentanyl citrate (OTFC) - 20-25 micrograms/kg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Oral solution of meperidine (1.5 mg/kg), diazepam (0.2 mg/kg), and atropine (0.02 mg/kg)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Oral transmucosal fentanyl citrate (OTFC)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Oral solution of meperidine, diazepam, and atropine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 30043997

Group type: EXPERIMENTAL
Intervention: Early rehabilitation
Number of subjects: 50

Group type: COMPARATOR
Intervention: Delayed rehabilitation
Number of subjects: 50
Study: 27266281

Group type: EXPERIMENTAL
Intervention: Nebulised magnesium sulphate (MS) 151 mg/dose with ipratropium bromide (IB) 500 µg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo with ipratropium bromide (IB) 500 µg
Number of subjects: 20
Study: 25162691

Group type: EXPERIMENTAL
Intervention: Follow-up telephone call by a non-health care provider 12 hours after ED visit
Number of subjects: 371

Group type: COMPARATOR
Intervention: No follow-up call
Number of subjects: 371
Study: 21500238

Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy for Binge Eating Disorder (DBT‐BED)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Active Comparison Group Control (ACGT)
Number of subjects: 101
Study: 19732303

Group type: EXPERIMENTAL
Intervention: Vardenafil nightly
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Vardenafil on demand
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 18574928

Group type: EXPERIMENTAL
Intervention: Ximelagatran
Number of subjects: 7329

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 7329

Group type: EXPERIMENTAL
Intervention: Ximelagatran and Warfarin
Number of subjects: 7329
Study: 15831831

Group type: EXPERIMENTAL
Intervention: Gavestinel
Number of subjects: 571

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 571
Study: 12435652

Group type: EXPERIMENTAL
Intervention: Ligament augmentation device
Number of subjects: 100

Group type: COMPARATOR
Intervention: No ligament augmentation device (control)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 100
Study: 10354252

Group type: EXPERIMENTAL
Intervention: Pneumonia severity index (PSI)
Number of subjects: 1024

Group type: EXPERIMENTAL
Intervention: Recalibrated PSI
Number of subjects: 1024
Study: 7495203

Group type: EXPERIMENTAL
Intervention: Sulphapyridine
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Cyproheptadine
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Chlorpheniramine
Number of subjects: 18

Group type: COMPARATOR
Intervention: Unmedicated controls
Number of subjects: 18
Study: 1940965

Group type: EXPERIMENTAL
Intervention: CDP‐choline (1 g)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 7038950

Group type: EXPERIMENTAL
Intervention: Doxapram hydrochloride infusions
Number of subjects: 93

Group type: COMPARATOR
Intervention: Control (no doxapram)
Number of subjects: 93
Study: 31048443

Group type: EXPERIMENTAL
Intervention: Intranasal inoculation of genetically modified N. lactamica expressing the meningococcal antigen NadA
Number of subjects: 100

Group type: COMPARATOR
Intervention: Genetically modified, but wild‐type equivalent control strain
Number of subjects: 100
Study: 30049309

Group type: EXPERIMENTAL
Intervention: Etripamil nasal spray (various doses)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Etripamil nasal spray
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Etripamil nasal spray (highest dose)
Number of subjects: 104
Study: 27338522

Group type: COMPARATOR
Intervention: Continuous local anesthetic infiltration wound catheter (CLAIWC) for 48 hours
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Transversus abdominis plane (TAP) block with ropivacaine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (TAP and CLAIWC)
Number of subjects: 60
Study: 23833240

Group type: EXPERIMENTAL
Intervention: Robotic-assisted hysterectomy
Number of subjects: 105

Group type: COMPARATOR
Intervention: Conventional laparoscopy
Number of subjects: 105
Study: 22104564

Group type: EXPERIMENTAL
Intervention: Adjuvant interferon alfa‐2b (IFNα‐2b) therapy for 53 weeks
Number of subjects: 268

Group type: COMPARATOR
Intervention: Observation alone (Control)
Number of subjects: 268

Group type: EXPERIMENTAL
Intervention: Adjuvant interferon alfa‐2b (IFNα‐2b) therapy
Number of subjects: 268
Study: 19156973

Group type: EXPERIMENTAL
Intervention: 0.3 mg kg(‐1) rocuronium
Number of subjects: 25

Group type: COMPARATOR
Intervention: Propofol and sufentanil (anaesthesia)
Number of subjects: 25
Study: 17000947

Group type: EXPERIMENTAL
Intervention: Multidisciplinary disease management trial
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Risk score for mortality based on 7 independent predictor variables
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Cox proportional hazards model
Number of subjects: 282
Study: 12594136

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 60

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 60
Study: 11037045

Group type: EXPERIMENTAL
Intervention: Happy facial stimuli
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Angry facial stimuli
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Left side of the face
Number of subjects: 32
Study: 9004102

Group type: EXPERIMENTAL
Intervention: losartan
Number of subjects: 24

Group type: COMPARATOR
Intervention: atenolol
Number of subjects: 24
Study: 1458806

Group type: EXPERIMENTAL
Intervention: 15% ketoprofen lysine salt foam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6385607

Group type: EXPERIMENTAL
Intervention: Mucosolvan (60 mg X 2 daily)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 31291337

Group type: EXPERIMENTAL
Intervention: Computer-based cognitive training (CCT)
Number of subjects: 631
Study: 28508561

Group type: EXPERIMENTAL
Intervention: Oral diclofenac 4 h before IVI and topical diclofenac 45 min before IVI
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Topical diclofenac 45 min before IVI
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo before IVI
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Both treatment groups (oral and topical diclofenac)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 25382404

Group type: EXPERIMENTAL
Intervention: Pleurotus ostreatus (P.o) and Pleurotus cystidiosus (P.c) at a dose of 50 mg/kg/body weight
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pleurotus ostreatus (P.o) and Pleurotus cystidiosus (P.c) in rats
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pleurotus cystidiosus (P.c) in rats
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pleurotus ostreatus (P.o) and Pleurotus cystidiosus (P.c)
Number of subjects: 0
Study: 22871565

Group type: EXPERIMENTAL
Intervention: Radial artery (RA) graft
Number of subjects: 5

Group type: COMPARATOR
Intervention: Saphenous vein (SV) graft
Number of subjects: 5
Study: 21849415

Group type: EXPERIMENTAL
Intervention: Nicotine mouth spray 4 mg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Nicotine mouth spray 2 mg
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Nicotine mouth spray 1 mg
Number of subjects: 45

Group type: COMPARATOR
Intervention: Nicotine lozenge 4 mg
Number of subjects: 45

Group type: COMPARATOR
Intervention: Nicotine gum 4 mg
Number of subjects: 45
Study: 19131578

Group type: EXPERIMENTAL
Intervention: Forced Exercise (FE)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Voluntary Exercise (VE)
Number of subjects: 10
Study: 16332282

Group type: EXPERIMENTAL
Intervention: Standard treatment plus self-help
Number of subjects: 96

Group type: COMPARATOR
Intervention: Standard treatment alone
Number of subjects: 96
Study: 15061344

Group type: EXPERIMENTAL
Intervention: Transference‐Focused Psychotherapy (TFP)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Dialectical Behavior Therapy (DBT)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Supportive Psychotherapy
Number of subjects: 90
Study: 11470636

Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation (200,000 IU)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Nutritional regimen (Control)
Number of subjects: 68
Study: 9513843

Group type: EXPERIMENTAL
Intervention: Metrodin-HP
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pergonal
Number of subjects: 0
Study: 8057661

Group type: EXPERIMENTAL
Intervention: Intensified protocol with high-dose chemotherapy and autologous or allogeneic bone marrow transplantation
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: 5 days of etoposide and cytarabine
Number of subjects: 88

Group type: COMPARATOR
Intervention: Standard treatment from previous trials
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Age as a factor in prognosis
Number of subjects: 88
Study: 2923766

Group type: EXPERIMENTAL
Intervention: Plain 0.5% bupivacaine 3 ml
Number of subjects: 40

Group type: COMPARATOR
Intervention: Plain 0.25% bupivacaine 6 ml
Number of subjects: 40
Study: 29984832

Group type: EXPERIMENTAL
Intervention: Novel chocolate-based tablet formulation of midazolam (0.5 mg.kg−1)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Intravenous solution of midazolam (0.5 mg.kg−1)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Novel chocolate-based tablet formulation of midazolam
Number of subjects: 150
Study: 28723796

Group type: EXPERIMENTAL
Intervention: Moist Exposed Burn Ointment (MEBO)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 26264543

Group type: EXPERIMENTAL
Intervention: 6 hours of lighted REST
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 6 hours of unlighted REST
Number of subjects: 30

Group type: COMPARATOR
Intervention: 6 hours of normal stimulation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Comparison between lighted REST and unlighted REST
Number of subjects: 30
Study: 24011548

Group type: EXPERIMENTAL
Intervention: Intra-aortic balloon pump (IABP)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control
Number of subjects: 600
Study: 20842388

Group type: EXPERIMENTAL
Intervention: PEEK cage
Number of subjects: 26

Group type: COMPARATOR
Intervention: PLDLLA cage
Number of subjects: 26
Study: 18310694

Group type: COMPARATOR
Intervention: Nonoperative treatment (28 knees)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Operative treatment (36 knees)
Number of subjects: 71
Study: 16551820

Group type: EXPERIMENTAL
Intervention: Continuous suture technique
Number of subjects: 139

Group type: COMPARATOR
Intervention: Interrupted suture technique
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: Both techniques
Number of subjects: 139
Study: 12970272

Group type: EXPERIMENTAL
Intervention: 30 mCi (131)I with rhTSH stimulation after stopping L-T4
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 30 mCi (131)I in hypothyroid state after L-T4 withdrawal
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group receiving rhTSH without stopping L-T4
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Group 1 urinary iodine
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Group 2 urinary iodine
Number of subjects: 40
Study: 10965635

Group type: EXPERIMENTAL
Intervention: Exposure and Ritual Prevention (EX/RP)
Number of subjects: 110
Study: 9258101

Group type: EXPERIMENTAL
Intervention: Preoperative and postoperative subcutaneous heparin
Number of subjects: 579

Group type: COMPARATOR
Intervention: No heparin
Number of subjects: 579
Study: 7801583

Group type: EXPERIMENTAL
Intervention: Subtotal body irradiation
Number of subjects: 43
Study: 2438924

Group type: EXPERIMENTAL
Intervention: Pirmenol hydrochloride 300 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pirmenol hydrochloride 400 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30097702

Group type: EXPERIMENTAL
Intervention: Toluene (200 ppm)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Clean air (control)
Number of subjects: 17
Study: 28566338

Group type: EXPERIMENTAL
Intervention: Radial artery (RA) graft
Number of subjects: 2737

Group type: COMPARATOR
Intervention: Saphenous vein graft (SVG)
Number of subjects: 2737
Study: 24478320

Group type: EXPERIMENTAL
Intervention: Enzalutamide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 22399700

Group type: EXPERIMENTAL
Intervention: Daily exercise (30 min of cycling exercise at 50% maximal workload capacity)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Exercise performed every other day (60 min of cycling exercise at 50% maximal workload capacity)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No exercise (control)
Number of subjects: 30
Study: 20808252

Group type: EXPERIMENTAL
Intervention: Pemetrexed plus cisplatin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gemcitabine plus cisplatin
Number of subjects: 0
Study: 17961015

Group type: EXPERIMENTAL
Intervention: Section of the terminal filum
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 15503125

Group type: EXPERIMENTAL
Intervention: Maximal apneas (3 apneas separated by 2 min rest)
Number of subjects: 10
Study: 12552940

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: Early intensification chemotherapy
Number of subjects: 505

Group type: EXPERIMENTAL
Intervention: ICE regimen (ifosfamide, carboplatin, etoposide) and CBP regimen (cyclophosphamide, cisplatin, carmustine)
Number of subjects: 505